These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30501173)

  • 21. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.
    Sorrentino F; Gonzalez del Rio R; Zheng X; Presa Matilla J; Torres Gomez P; Martinez Hoyos M; Perez Herran ME; Mendoza Losana A; Av-Gay Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):640-5. PubMed ID: 26503663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.
    Grzelak EM; Choules MP; Gao W; Cai G; Wan B; Wang Y; McAlpine JB; Cheng J; Jin Y; Lee H; Suh JW; Pauli GF; Franzblau SG; Jaki BU; Cho S
    J Antibiot (Tokyo); 2019 Oct; 72(10):719-728. PubMed ID: 31292530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of compound kill kinetics against Mycobacterium tuberculosis.
    Early J; Alling T
    Methods Mol Biol; 2015; 1285():269-79. PubMed ID: 25779322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis.
    Bonnett S; Jee JA; Chettiar S; Ovechkina Y; Korkegian A; Greve E; Odingo J; Parish T
    Microbiol Spectr; 2023 Feb; 11(1):e0497422. PubMed ID: 36688635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
    Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
    J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
    Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
    PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
    Vocat A; Hartkoorn RC; Lechartier B; Zhang M; Dhar N; Cole ST; Sala C
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4012-9. PubMed ID: 25896710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
    Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
    J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium tuberculosis High-Throughput Screening.
    White EL; Tower NA; Rasmussen L
    Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel MenA Inhibitors Are Bactericidal against
    Berube BJ; Russell D; Castro L; Choi SR; Narayanasamy P; Parish T
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962346
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Cho SH; Warit S; Wan B; Hwang CH; Pauli GF; Franzblau SG
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1380-5. PubMed ID: 17210775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating
    Lopez Quezada L; Li K; McDonald SL; Nguyen Q; Perkowski AJ; Pharr CW; Gold B; Roberts J; McAulay K; Saito K; Somersan Karakaya S; Javidnia PE; Porras de Francisco E; Amieva MM; Dı Az SP; Mendoza Losana A; Zimmerman M; Liang HH; Zhang J; Dartois V; Sans S; Lagrange S; Goullieux L; Roubert C; Nathan C; Aubé J
    ACS Infect Dis; 2019 Aug; 5(8):1433-1445. PubMed ID: 31184461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high-throughput cidality screen for Mycobacterium tuberculosis.
    Kaur P; Ghosh A; Krishnamurthy RV; Bhattacharjee DG; Achar V; Datta S; Narayanan S; Anbarasu A; Ramaiah S
    PLoS One; 2015; 10(2):e0117577. PubMed ID: 25693161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
    J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.